title: Letter regarding 'Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate'.
authors.forename: Michael D L
authors.initials: MD
authors.lastname: Smyth
authors.forename: Raymond D
authors.initials: RD
authors.lastname: Pratt
mesh_terms: D002614:Chelating Agents / Q000627:therapeutic use*; D000075202:Contraindications; D003287:Contrast Media / Q000009:adverse effects* / Q000627:therapeutic use; D005682:Gadolinium / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D007811:Lanthanum / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D014511:Uremia / Q000188:drug therapy*
chemical_list: D002614:Chelating Agents; D003287:Contrast Media; C119467:lanthanum carbonate; D007811:Lanthanum; D005682:Gadolinium